21.36
0.10 (0.47%)
| Previous Close | 21.26 |
| Open | 21.29 |
| Volume | 1,082,729 |
| Avg. Volume (3M) | 5,984,640 |
| Market Cap | 14,537,915,392 |
| Price / Earnings (TTM) | 47.47 |
| Price / Earnings (Forward) | 18.66 |
| Price / Sales | 2.11 |
| Price / Book | 2.59 |
| 52 Weeks Range | |
| Earnings Date | 12 Feb 2025 - 17 Feb 2025 |
| Profit Margin | 4.54% |
| Operating Margin (TTM) | 7.31% |
| Diluted EPS (TTM) | 0.450 |
| Quarterly Revenue Growth (YOY) | -0.30% |
| Quarterly Earnings Growth (YOY) | -46.70% |
| Total Debt/Equity (MRQ) | 88.62% |
| Current Ratio (MRQ) | 1.54 |
| Operating Cash Flow (TTM) | 919.10 M |
| Levered Free Cash Flow (TTM) | 658.37 M |
| Return on Assets (TTM) | 3.27% |
| Return on Equity (TTM) | 5.81% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Avantor, Inc. | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | 3.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 0.5 |
| Average | 2.63 |
|
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Mid Core |
| % Held by Insiders | 1.25% |
| % Held by Institutions | 102.81% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| New Mountain Capital, L.L.C. | 30 Sep 2024 | 14,000,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 29.00 (UBS, 35.77%) | Buy |
| Median | 27.00 (26.40%) | |
| Low | 25.00 (Barclays, 17.04%) | Buy |
| Average | 27.00 (26.40%) | |
| Total | 4 Buy | |
| Avg. Price @ Call | 23.13 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Baird | 28 Oct 2024 | 26.00 (21.72%) | Buy | 22.64 |
| Wells Fargo | 28 Oct 2024 | 28.00 (31.09%) | Buy | 22.64 |
| Barclays | 25 Oct 2024 | 25.00 (17.04%) | Buy | 22.43 |
| UBS | 08 Oct 2024 | 29.00 (35.77%) | Buy | 24.80 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |